Identification of Pharmacological Targets in Amyotrophic Lateral Sclerosis Through Genomic Analysis of Deregulated Genes and Pathways

By  

Current Genomics, Vol. 13, Iss. 4, 2012-06 ,pp. : 321-333

Bentham Science Publishers

Access to resources Recommend Favorite

The unfolded protein response in familial amyotrophic lateral sclerosis

By Wang Lijun   Popko Brian   Roos Raymond P.  

Human Molecular Genetics, Vol. 20, Iss. 5, 2011-03 ,pp. : 1008-1015

Oxford University Press

Access to resources Recommend Favorite

SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments

By Joyce Peter  

Mammalian Genome, Vol. 22, Iss. 7-8, 2011-08 ,pp. : 420-448

Springer Publishing Company

Access to resources Recommend Favorite

Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds

By Ratovitski Tamara  

Human Molecular Genetics, Vol. 8, Iss. 8, 1999-08 ,pp. : 1451-1460

Oxford University Press

Access to resources Recommend Favorite

Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons

By Subramanian Vasanta   Crabtree Benedict   Acharya K. Ravi  

Human Molecular Genetics, Vol. 17, Iss. 1, 2008-01 ,pp. : 130-149

Oxford University Press

Access to resources Recommend Favorite